Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Technology enhances human design thinking, creating new possibilities.

Technology expands design thinking possibilities, requiring a hybrid, reflective approach.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Trichoscopy is crucial for diagnosing and managing androgenetic alopecia, showing increased vellus hairs, empty follicles, and fibrosis with severity.

Aging causes hair to gray and thin, with the timing of graying varying by race, and factors like oxidative stress and genetics can lead to hair loss.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Ginseng and Albizia extracts may help prevent age-related hair thinning.

Two women with darker skin had both frontal hair thinning and skin discoloration.

Versican, a protein, is less present in thinning hair follicles and this decrease might contribute to common hair loss in men.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Hair thinning causes stem cell loss through a process involving Piezo1, calcium, and TNF-α.

New treatment effectively reverses hair thinning in most patients with mild side effects.

A woman's temporary hair loss after face lift surgery stopped on its own, and hair grew back.

Mutations in the AR gene cause hair thinning and loss.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

Hair transplant destroyed by lichen planopilaris.

SA linked to mitochondrial issues and oxidative stress, while AGA involves disrupted hair growth genes.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

PCOS often causes skin issues like excess hair, acne, hair thinning, and dark patches due to hormone imbalances and insulin resistance.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Minoxidil affects cell growth in two ways: low doses increase growth, while high doses slow it down and can be toxic.

Hair stem cells produce a protein called COL17A1 that plays a key role in their development and is linked to hair thinning and baldness.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.